Search

Your search keyword '"Kollàr, Attila"' showing total 15 results
Start Over Author "Kollàr, Attila"
15 results on '"Kollàr, Attila"'

2. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

Author

Andreou, Dimosthenis, Barth, Thomas, Bauer, Sebastian, Blay, Jean-Yves, Blum, Veronika, Bode, Beata, Bonvalot, Sylvie, Bovee, Judith, Braam, Petra, Brodowicz, Thomas, Broto, Jean Martin, Dei Tos, Angelo, Denschlag, Dominik, Desar, Ingrid, Digklia, Antonia, Dileo, Palma, Dirksen, Uta, Douchy, Thomas, Duffaud, Florence, Eriksson, Mikael, Fröhling, Stefan, Gelderblom, Hans, Gronchi, Alessandro, Haas, Rick, Hardes, Jenrik, Hartmann, Wolfgang, Hofer, Silvia, Hohenberger, Peter, Hompes, Daphne, Huang, Paul, Italiano, Antoine, Jakob, Jens, Jones, Robin, Judson, Ian, Köhler, Günter, Kollàr, Attila, Krasniqi, Fatime, Krol, Stijn, Kunz, Wolfgang, Le Grange, Franel, Le Pechoux, Cécile, LeCesne, Alexandre, Leithner, Andreas, Liegl-Atzwanger, Bernadette, Lindner, Lars, Mechtersheimer, Gunhild, Messiou, Christina, Miah, Aisha, Pink, Daniel, Reichardt, Peter, Romagosa, Cleo, Rothermundt, Christian, Rutkowski, Piotr, Safwat, Akmel, Sangalli, Claudia, Szkandera, Joanna, Thway, Khin, Tunn, Per-Ulf, Van der Graaf, Winette, Van Houdt, Winan, Wardelmann, Eva, Zachariah, Ralph, Botter, Sander, Cerny, Thomas, Desar, Ingrid M.E., Jones, Robin L., Kunz, Wolfgang G., Liegl-Atzwanger, Berndadette, Lindner, Lars H., Miah, Aisha B., van der Graaf, Winette T.A., and van Houdt, Winan J.

Published
2023
Full Text
View/download PDF

4. Pathologic Fractures

Author

Klenke, Frank M., Kollár, Attila, Kurze, Christophe, Castoldi, Filippo, Series Editor, Bonasia, Davide Edoardo, Series Editor, Büchler, Lorenz, editor, and Keel, Marius J.B., editor

Published
2019
Full Text
View/download PDF

8. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

Author

Rothermundt, Christian, primary, Andreou, Dimosthenis, additional, Blay, Jean-Yves, additional, Brodowicz, Thomas, additional, Desar, Ingrid M.E., additional, Dileo, Palma, additional, Gelderblom, Hans, additional, Haas, Rick, additional, Jakob, Jens, additional, Jones, Robin L., additional, Judson, Ian, additional, Kunz, Wolfgang G., additional, Liegl-Atzwanger, Berndadette, additional, Lindner, Lars H., additional, Messiou, Christina, additional, Miah, Aisha B., additional, Reichardt, Peter, additional, Szkandera, Joanna, additional, van der Graaf, Winette T.A., additional, van Houdt, Winan J., additional, Wardelmann, Eva, additional, Hofer, Silvia, additional, Barth, Thomas, additional, Bauer, Sebastian, additional, Blum, Veronika, additional, Bode, Beata, additional, Bonvalot, Sylvie, additional, Bovee, Judith, additional, Braam, Petra, additional, Broto, Jean Martin, additional, Dei Tos, Angelo, additional, Denschlag, Dominik, additional, Desar, Ingrid, additional, Digklia, Antonia, additional, Dirksen, Uta, additional, Douchy, Thomas, additional, Duffaud, Florence, additional, Eriksson, Mikael, additional, Fröhling, Stefan, additional, Gronchi, Alessandro, additional, Hardes, Jenrik, additional, Hartmann, Wolfgang, additional, Hohenberger, Peter, additional, Hompes, Daphne, additional, Huang, Paul, additional, Italiano, Antoine, additional, Jones, Robin, additional, Köhler, Günter, additional, Kollàr, Attila, additional, Krasniqi, Fatime, additional, Krol, Stijn, additional, Kunz, Wolfgang, additional, Le Grange, Franel, additional, Le Pechoux, Cécile, additional, LeCesne, Alexandre, additional, Leithner, Andreas, additional, Liegl-Atzwanger, Bernadette, additional, Lindner, Lars, additional, Mechtersheimer, Gunhild, additional, Miah, Aisha, additional, Pink, Daniel, additional, Romagosa, Cleo, additional, Rothermundt, Christian, additional, Rutkowski, Piotr, additional, Safwat, Akmel, additional, Sangalli, Claudia, additional, Thway, Khin, additional, Tunn, Per-Ulf, additional, Van der Graaf, Winette, additional, Van Houdt, Winan, additional, Zachariah, Ralph, additional, Botter, Sander, additional, and Cerny, Thomas, additional

Published
2023
Full Text
View/download PDF

9. Patient-derived tumoroids of advanced high-grade neuroendocrine neoplasms mimic patient chemotherapy responses and guide the design of personalized combination therapies

Author

April-Monn, Simon L., primary, Detjen, Katharina, additional, Kirchner, Philipp, additional, Bräutigam, Konstantin, additional, Trippel, Mafalda A., additional, Grob, Tobias, additional, Statzer, Cyril, additional, Maire, Renaud S., additional, Kollàr, Attila, additional, Chouchane, Aziz, additional, Kunze, Catarina A., additional, Horst, David, additional, Sadowski, Martin C., additional, Schrader, Jörg, additional, Marinoni, Ilaria, additional, Wiedenmann, Bertram, additional, and Perren, Aurel, additional

Published
2022
Full Text
View/download PDF

14. Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program

Author

Kollàr, Attila, primary, Maruzzo, Marco, additional, Messiou, Christina, additional, Cartwright, Elisabeth, additional, Miah, Aisha, additional, Martin-Liberal, Juan, additional, Thway, Khin, additional, McGrath, Ellen, additional, Dunlop, Alison, additional, Khabra, Komel, additional, Seddon, Beatrice, additional, Dileo, Palma, additional, Linch, Mark, additional, Judson, Ian, additional, and Benson, Charlotte, additional

Published
2014
Full Text
View/download PDF

15. Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study.

Author

Noujaim J, Thway K, Jones RL, Miah A, Khabra K, Langer R, Kasper B, Judson I, Benson C, and Kollàr A

Subjects
Adult, Aged, Aged, 80 and over, Doxorubicin administration & dosage, Etoposide administration & dosage, Female, Follow-Up Studies, Humans, Ifosfamide administration & dosage, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local mortality, Neoplasm Staging, Prognosis, Prospective Studies, Retrospective Studies, Rhabdomyosarcoma mortality, Survival Rate, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Neoplasm Recurrence, Local drug therapy, Neoplasm Recurrence, Local pathology, Rhabdomyosarcoma drug therapy, Rhabdomyosarcoma pathology
Abstract

Background: Pleomorphic rhabdomyosarcoma (RMS) is a rare sub-type of RMS. Optimal treatment remains undefined., Patients and Methods: Between 1995 and 2014, 45 patients were diagnosed and treated in three tertiary sarcoma Centers (United Kingdom, Switzerland and Germany). Treatment characteristics and outcomes were analyzed., Results: The median age at diagnosis was 71.5 years (range=28.4-92.8 years). Median survival for those with localised (n=32, 71.1%) and metastatic disease (n=13, 28.9%) were 12.8 months (95% confidence interval=8.2-34.4) and 7.1 months (95% confidence interval=3.8-11.3) respectively. The relapse rate was 53.8% (four local and 10 distant relapses). In total, 14 (31.1%) patients received first line palliative chemotherapy including multi-agent paediatric chemotherapy schedules (n=3), ifosfamide-doxorubicin (n=4) and single-agent doxorubicin (n=7). Response to chemotherapy was poor (one partial remission with vincristine-actinomycin D-cyclophosphamide and six cases with stable disease). Median progression-free survival was 2.3 (range=1.2-7.3) months., Conclusion: Pleomorphic RMS is an aggressive neoplasm mainly affecting older patients, associated with a high relapse rate, a poor and short-lived response to standard chemotherapy and an overall poor prognosis for both localised and metastatic disease., (Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.)

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results